In February 2022, it was announced that Genome Explorations, Inc. had been acquired by Arizona based Tesis Biosciences - itself in the business of targeted genetic sequencing and comprehensive genetic data collection that transform chronic disease management. Genome Explorations USA had been structured around providing global genomic profiling and molecular diagnostics services to academic centers, pharmaceutical and biotech industry, to oncologists, and pathologists with innovative diagnostic, prognostic, predictive, and personalized testing offering a combination of quality diagnostics, industry-leading innovation, and quality service. Organized around providing a 'Complete Solutionâ for RNA, miRNA and DNA analysis, the firm provide all associated Bioinformatic solutions to make sence of the data generated through these high through put technologies. Originally launched and managed the Genomics Core Facility at St. Jude Childrenâs Research Hospital, the effort was to pioneer use of global genomics to enhance diagnosis of pediatric leukemia and evaluate prognostic outcome in patients. Clients provide their biological samples (DNA, RNA, Cells, Tissue or Blood) and the firm's staff process these samples to completion and analyze them using the latest advanced bioinformatics solutio
